Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Amylyx Pharmaceuticals Shares Outstanding 2021-2025 | AMLX

Amylyx Pharmaceuticals shares outstanding from 2021 to 2025. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Amylyx Pharmaceuticals Annual Shares Outstanding
(Millions of Shares)
2024 68
2023 70
2022 58
2021 7
2020 6
Amylyx Pharmaceuticals Quarterly Shares Outstanding
(Millions of Shares)
2025-06-30 89
2025-03-31 86
2024-12-31 68
2024-09-30 68
2024-06-30 68
2024-03-31 68
2023-12-31 70
2023-09-30 70
2023-06-30 70
2023-03-31 71
2022-12-31 58
2022-09-30 59
2022-06-30 58
2022-03-31 52
2021-12-31 7
2021-09-30 7
2021-06-30 6
2021-03-31 6
2020-12-31
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $1.181B $0.087B
Amylyx Pharmaceuticals Inc. is a clinical-stage pharmaceutical company. It focuses on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. Amylyx Pharmaceuticals Inc. is based in CAMBRIDGE, Mass.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $75.529B 28.69
Zoetis (ZTS) United States $53.099B 19.00
Takeda Pharmaceutical (TAK) Japan $43.243B 8.82
Daiichi Sankyo, - (DSNKY) Japan $42.092B 20.96
BeOne Medicines - (ONC) Switzerland $35.245B 0.00
Sandoz Group AG (SDZNY) Switzerland $29.520B 0.00
United Therapeutics (UTHR) United States $19.266B 16.95
Merck (MKKGY) Germany $16.414B 10.67
Neurocrine Biosciences (NBIX) United States $15.330B 36.78
Shionogi (SGIOY) Japan $14.275B 13.11
Summit Therapeutics (SMMT) United States $13.935B 0.00
Ionis Pharmaceuticals (IONS) United States $12.096B 0.00
IPSEN (IPSEY) France $12.095B 0.00
Madrigal Pharmaceuticals (MDGL) United States $10.808B 0.00
Orion OYJ (ORINY) Finland $9.208B 26.31
Eisai (ESAIY) $8.260B 0.00
Corcept Therapeutics (CORT) United States $8.063B 87.10
Stevanato Group S.p.A (STVN) Italy $7.571B 44.64
Grifols, S.A (GRFS) Spain $5.934B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.730B 17.43
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.142B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $4.294B 0.00
Crinetics Pharmaceuticals (CRNX) United States $4.005B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $3.672B 17.45
Centessa Pharmaceuticals (CNTA) United Kingdom $3.016B 0.00
Dyne Therapeutics (DYN) United States $2.973B 0.00
Hypermarcas (HYPMY) Brazil $2.936B 22.07
Catalyst Pharmaceuticals (CPRX) United States $2.617B 8.38
Soleno Therapeutics (SLNO) United States $2.517B 0.00
Ocular Therapeutix (OCUL) United States $2.303B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.905B 22.58
Avadel Pharmaceuticals (AVDL) Ireland $1.841B 0.00
Guardian Pharmacy Services (GRDN) United States $1.836B 0.00
Xeris Biopharma Holdings (XERS) United States $1.594B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.510B 89.62
Ardelyx (ARDX) United States $1.446B 0.00
Harrow (HROW) United States $1.311B 0.00
Evotec AG (EVO) Germany $1.188B 0.00
Oruka Therapeutics (ORKA) United States $1.134B 0.00
Collegium Pharmaceutical (COLL) United States $1.129B 6.17
Relay Therapeutics (RLAY) United States $1.129B 0.00
Enliven Therapeutics (ELVN) United States $1.096B 0.00
Nektar Therapeutics (NKTR) United States $1.032B 0.00
Xencor (XNCR) United States $1.025B 0.00
Cronos Group (CRON) Canada $0.938B 0.00
ARS Pharmaceuticals (SPRY) United States $0.894B 0.00
ProKidney (PROK) United States $0.795B 0.00
Theravance Biopharma (TBPH) United States $0.753B 62.29
Savara (SVRA) United States $0.697B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.687B 6.13
Elite Pharmaceuticals (ELTP) United States $0.660B 0.00
Bioventus (BVS) United States $0.610B 12.51
Siga Technologies (SIGA) United States $0.604B 7.46
Aquestive Therapeutics (AQST) United States $0.598B 0.00
Esperion Therapeutics (ESPR) United States $0.593B 0.00
Zevra Therapeutics (ZVRA) United States $0.565B 0.00
Akebia Therapeutics (AKBA) United States $0.562B 0.00
KalVista Pharmaceuticals (KALV) United States $0.555B 0.00
Organogenesis (ORGO) United States $0.504B 0.00
4D Molecular Therapeutics (FDMT) United States $0.491B 0.00
Lexeo Therapeutics (LXEO) United States $0.443B 0.00
USANA Health Sciences (USNA) United States $0.373B 10.41
Galectin Therapeutics (GALT) United States $0.363B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.335B 51.50
Altimmune (ALT) United States $0.331B 0.00
Lyell Immunopharma (LYEL) United States $0.318B 0.00
Korro Bio (KRRO) United States $0.304B 0.00
Aldeyra Therapeutics (ALDX) United States $0.295B 0.00
Larimar Therapeutics (LRMR) United States $0.267B 0.00
Achieve Life Sciences (ACHV) Canada $0.252B 0.00
Nature's Sunshine Products (NATR) United States $0.249B 16.24
Aclaris Therapeutics (ACRS) United States $0.245B 0.00
Pyxis Oncology (PYXS) United States $0.243B 0.00
Journey Medical (DERM) United States $0.233B 0.00
AleAnna (ANNA) United States $0.217B 0.00
Avalo Therapeutics (AVTX) United States $0.216B 0.00
OmniAb (OABI) United States $0.205B 0.00
Heron Therapeutics (HRTX) United States $0.204B 0.00
MediWound (MDWD) Israel $0.201B 0.00
China SXT Pharmaceuticals (SXTC) China $0.193B 0.00
Profound Medical (PROF) Canada $0.177B 0.00
Protara Therapeutics (TARA) United States $0.171B 0.00
Innate Pharma SA (IPHYF) France $0.168B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.159B 0.00
Cassava Sciences (SAVA) United States $0.147B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.134B 0.00
Incannex Healthcare (IXHL) Australia $0.131B 0.00
Inhibikase Therapeutics (IKT) United States $0.127B 0.00
Cardiol Therapeutics (CRDL) Canada $0.108B 0.00
Surrozen (SRZN) United States $0.106B 0.00
Context Therapeutics (CNTX) United States $0.101B 0.00
Champions Oncology (CSBR) United States $0.094B 34.00
Avita Medical (RCEL) United States $0.093B 0.00
Vivani Medical (VANI) United States $0.093B 0.00
Metagenomi (MGX) United States $0.085B 0.00
Relmada Therapeutics (RLMD) United States $0.083B 0.00
Unicycive Therapeutics (UNCY) United States $0.081B 0.00
Prelude Therapeutics (PRLD) United States $0.079B 0.00
Dominari Holdings (DOMH) United States $0.078B 0.00
VAXART, INC (VXRT) United States $0.076B 0.00
Assertio Holdings (ASRT) United States $0.072B 0.00
Nutriband (NTRB) United States $0.072B 0.00
Procaps Group, S.A (PROCF) Luxembourg $0.071B 0.00
PMV Pharmaceuticals (PMVP) United States $0.069B 0.00
BioNxt Solutions (BNXTF) Canada $0.069B 0.00
Gain Therapeutics (GANX) United States $0.066B 0.00
Lite Strategy (LITS) United States $0.066B 0.00
Acrivon Therapeutics (ACRV) United States $0.064B 0.00
PolyPid (PYPD) Israel $0.060B 0.00
Talphera (TLPH) United States $0.059B 0.00
Wellgistics Health (WGRX) United States $0.059B 0.00
Fractyl Health (GUTS) United States $0.057B 0.00
Plus Therapeutics (PSTV) United States $0.054B 0.00
NRx Pharmaceuticals (NRXP) United States $0.053B 0.00
Century Therapeutics (IPSC) United States $0.048B 0.00
Jupiter Neurosciences (JUNS) United States $0.047B 0.00
Rafael Holdings (RFL) United States $0.047B 0.00
Karyopharm Therapeutics (KPTI) United States $0.046B 0.00
Telomir Pharmaceuticals (TELO) United States $0.045B 0.00
FibroGen (FGEN) United States $0.044B 0.00
Tempest Therapeutics (TPST) United States $0.044B 0.00
Inotiv (NOTV) United States $0.041B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.040B 0.00
ElectroCore (ECOR) United States $0.038B 0.00
Mural Oncology (MURA) Ireland $0.036B 0.00
Liminatus Pharma (LIMN) United States $0.035B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.035B 29.12
Klotho Neurosciences (KLTO) United States $0.033B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.033B 0.00
Iterum Therapeutics (ITRM) Ireland $0.030B 0.00
Scienture Holdings (SCNX) United States $0.027B 0.00
SCYNEXIS (SCYX) United States $0.026B 0.00
Enlivex Therapeutics (ENLV) Israel $0.024B 0.00
Citius Pharmaceuticals (CTXR) United States $0.023B 0.00
Cosmos Health (COSM) United States $0.022B 0.00
Vyome Holdings (HIND) United States $0.022B 0.00
Mangoceuticals (MGRX) United States $0.019B 0.00
Natural Alternatives (NAII) United States $0.018B 0.00
Vivos Therapeutics (VVOS) United States $0.018B 0.00
Mannatech (MTEX) United States $0.017B 0.00
Heatwurx (PCSA) United States $0.017B 0.00
CASI Pharmaceuticals (CASI) China $0.017B 0.00
Ainos (AIMD) United States $0.016B 0.00
Traws Pharma (TRAW) United States $0.015B 0.02
BioLineRx (BLRX) Israel $0.015B 0.00
Lipocine (LPCN) United States $0.014B 0.00
TherapeuticsMD (TXMD) United States $0.014B 0.00
Ernexa Therapeutics (ERNA) United States $0.013B 0.00
ProPhase Labs (PRPH) United States $0.012B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.012B 0.00
BioVie (BIVI) United States $0.012B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Lyra Therapeutics (LYRA) United States $0.009B 0.00
Phio Pharmaceuticals (PHIO) United States $0.009B 0.00
VYNE Therapeutics (VYNE) United States $0.009B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.008B 0.00
TransCode Therapeutics (RNAZ) United States $0.008B 0.00
Biomerica (BMRA) United States $0.008B 0.00
Aptorum Group (APM) United Kingdom $0.007B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.006B 0.00
Nuvilex (PMCB) United States $0.006B 0.00
Alaunos Therapeutics (TCRT) United States $0.006B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.006B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.006B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.005B 0.00
InMed Pharmaceuticals (INM) Canada $0.005B 0.00
Qualigen Therapeutics (QLGN) United States $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
Jaguar Animal Health (JAGX) United States $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
CDT Equity (CDT) United States $0.003B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
Indaptus Therapeutics (INDP) United States $0.003B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.003B 0.00
Universe Pharmaceuticals INC (UPC) China $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
NewcelX (NCEL) Switzerland $0.002B 0.00
SciSparc (SPRC) Israel $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Aditxt (ADTX) United States $0.000B 0.00
Curanex Pharmaceuticals Inc (CURX) United States $0.000B 0.00
Emisphere Technologies (EMIS) United States $0.000B 0.00
Indivior (INDV) United States $0.000B 16.35
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Minerva Neurosciences (NERV) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00